Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Quantitative Monitoring of NPM1A Mutations Can Be Used to Guide Immunotherapeutic Interventions After Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

Jessica C. Harskamp, MD, Joya E. Nahon, Andrea M. Siegel, Hans L. Vos, PhD, Piëette P. Deutz-Terlouw, J.Hendrik Veelken, MD, PhD, J.H. Frederik Falkenburg, MD, PhD, Erik W.A. Marijt, MD, PhD

Blood (2011) 118 (21): 3061.

https://doi.org/10.1182/blood.V118.21.3061.3061

Published: 2011

Journal Articles

T Cell Chimerism After T Cell Depleted Allogeneic Stem Cell Transplantation Is Influenced by Immunological Factors Including the Conditioning Regimen, CMV Serostatus and GvHD and Does Significantly Bias Overall Chimerism Status

Jessica C. Harskamp, MD, Pim L.J. van der Heiden, MD, Esther H.M. van Egmond, Sabrina A.J. Veld, Hans L. Vos, PhD, Constantijn J.M. Halkes, MD, PhD, J.H. Frederik Falkenburg, MD, PhD, Erik W.A. Marijt, MD, PhD

Blood (2010) 116 (21): 1321.

https://doi.org/10.1182/blood.V116.21.1321.1321

Published: 2010

Journal Articles

Myeloid Chimerism Reflects Engraftment of Donor Hematopoiesis, Whereas T Cell Chimerism Reflects Survival and Expansion of Donor and Recipient Residual Mature T Cells Early After T Cell Depleted Allogeneic Stem Cell Transplantation.

Jessica C. Harskamp, Esther H.M. van Egmond, Hans L. Vos, PhD, Stijn J.M. Halkes, MD, PhD, Roel Willemze, MD, PhD, J.H. Frederik Falkenburg, MD, PhD, Erik W.A. Marijt, MD, PhD

Blood (2009) 114 (22): 4475.

https://doi.org/10.1182/blood.V114.22.4475.4475

Published: 2009

Journal Articles

Elevated fibrinogen γ′ ratio is associated with cardiovascular diseases and acute phase reaction but not with clinical outcome

Elim Y. L. Cheung, Hans L. Vos, Marieke J. H. A. Kruip, Heleen M. den Hertog, J. Wouter Jukema, Moniek P. M. de Maat

Blood (2009) 114 (20): 4603–4604.

https://doi.org/10.1182/blood-2009-08-236240

Published: 2009

Journal Articles

Polymorphism 10034C>T Is Located in a Functional Cleavage Stimulation Factor (CstF) Binding Site of the Fibrinogen Gamma Gene and Influences the γ′/γA mRNA Ratio.

Shirley Uitte de Willige, MSc, Inge M. Rietveld, Marieke C.H. de Visser, PhD, Hans L. Vos, PhD, Rogier M. Bertina, PhD

Blood (2006) 108 (11): 543.

https://doi.org/10.1182/blood.V108.11.543.543

Published: 2006

Journal Articles

Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen γ′ levels

Shirley Uitte de Willige, Marieke C. H. de Visser, Jeanine J. Houwing-Duistermaat, Frits R. Rosendaal, Hans L. Vos, Rogier M. Bertina

Blood (2005) 106 (13): 4176–4183.

https://doi.org/10.1182/blood-2005-05-2180

Published: 2005

Journal Articles

The Marburg I polymorphism of factor VII-activating protease is not associated with venous thrombosis

Rick van Minkelen, Marieke C. H. de Visser, Hans L. Vos, Rogier M. Bertina, Frits R. Rosendaal

Blood (2005) 105 (12): 4898–4899.

https://doi.org/10.1182/blood-2005-02-0576

Published: 2005

Journal Articles

Is the prothrombin 19911A>G polymorphism a functional noncoding variant?

Haidy H. A. G. M. van der Putten, Rogier M. Bertina, Hans L. Vos

Blood (2005) 105 (7): 2995–2996.

https://doi.org/10.1182/blood-2004-10-4154

Published: 2005

Journal Articles

Genetic variants of coagulation factor XIII, postmenopausal estrogen therapy, and risk of nonfatal myocardial infarction

Alexander P. Reiner, Susan R. Heckbert, Hans L. Vos, Robert A. S. Ariëns, Rozenn N. Lemaitre, Nicholas L. Smith, Thomas Lumley, Thomas D. Rea, Lucia A. Hindorff, Gina D. Schellenbaum, Frits R. Rosendaal, David S. Siscovick, Bruce M. Psaty

Blood (2003) 102 (1): 25–30.

https://doi.org/10.1182/blood-2002-07-2308

Published: 2003

Journal Articles

A novel, possibly functional, single nucleotide polymorphism in the coding region of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated with TAFI levels

Geert-Jan Brouwers, Hans L. Vos, Frank W. G. Leebeek, Saskia Bulk, Mark Schneider, Michael Boffa, Marlys Koschinsky, Nico H. van Tilburg, Michael E. Nesheim, Rogier M. Bertina, Encarnación B. Gómez Garcı́a

Blood (2001) 98 (6): 1992–1993.

https://doi.org/10.1182/blood.V98.6.1992

Published: 2001

NARROW

Quantitative Monitoring of NPM1A Mutations Can Be Used to Guide Immunotherapeutic Interventions After Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

T Cell Chimerism After T Cell Depleted Allogeneic Stem Cell Transplantation Is Influenced by Immunological Factors Including the Conditioning Regimen, CMV Serostatus and GvHD and Does Significantly Bias Overall Chimerism Status

Myeloid Chimerism Reflects Engraftment of Donor Hematopoiesis, Whereas T Cell Chimerism Reflects Survival and Expansion of Donor and Recipient Residual Mature T Cells Early After T Cell Depleted Allogeneic Stem Cell Transplantation.

Elevated fibrinogen γ′ ratio is associated with cardiovascular diseases and acute phase reaction but not with clinical outcome

Polymorphism 10034C>T Is Located in a Functional Cleavage Stimulation Factor (CstF) Binding Site of the Fibrinogen Gamma Gene and Influences the γ′/γA mRNA Ratio.

Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen γ′ levels

The Marburg I polymorphism of factor VII-activating protease is not associated with venous thrombosis

Is the prothrombin 19911A>G polymorphism a functional noncoding variant?

Genetic variants of coagulation factor XIII, postmenopausal estrogen therapy, and risk of nonfatal myocardial infarction

A novel, possibly functional, single nucleotide polymorphism in the coding region of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated with TAFI levels

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only